<DOC>
	<DOCNO>NCT01833390</DOCNO>
	<brief_summary>The purpose clinical trial demonstrate hyperpolarized xenon ( HXe ) medical image drug ( agent ) Magnetic Resonance Imaging ( MRI ) human lung ventilation .</brief_summary>
	<brief_title>MagniXene MRI Use Patients With Asthma COPD Assess Regional Lung Function Delineating Ventilation Defects</brief_title>
	<detailed_description>HXe MRI provide diversity image technique interrogate pulmonary function lung microstructure . The mature techniques utilizes HXe spin-density MRI depict regional lung ventilation . Prior work suggest ventilation image utility obstructive lung disease . This Phase II clinical trial ass HXe MRI capability provide qualitative quantitative clinical information regard lung ventilation . Proton xenon image acquire within single breath hold 28 subject per year , include healthy volunteer patient COPD asthma . All study include repeat scan Pulmonary Function Tests ( PFT ) . Ventilation scan Technetium-99m ( Tc-99m ) diethylene-triamine-pentaacetate ( DTPA ) aerosol scintigraphy acquire lung patient . The primary goal aim validate effectiveness HXe ventilation MRI delineate region normal abnormal lung ventilation . To validate regional depiction ventilation , HXe MRI ventilation compare nuclear medicine Tc-99m DTPA ventilation scintigraphy . The comparatively low spatial temporal resolution ventilation scintigraphy limit study demonstrate HXe MRI ventilation inferior current clinical standard . Additionally , concordance measurement whole lung volume proton MRI HXe MRI PFT , current clinical standard lung volume measurement , assess secondary outcome study .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Xenon</mesh_term>
	<criteria>Inclusion Criteria ( healthy subject ) : Currently feel well without respiratory symptom . No history lung disease . Never personally smoke ( define less 100 cigarette lifetime ) . Inclusion Criteria ( COPD subject ) : Forced Expiratory Volume 1 second ( FEV1 ) &lt; 80 % predict OR FEV1 Forced Vital Capacity ( FVC ) ratio &lt; 70 % Smoking history &gt; 10 pack year Subjects clinical baseline day image Subjects must clinically stable order participate study Inclusion Criteria ( asthma subject ) : Greater 10 % increase FEV1 3050 minute administration albuterol ; Subjects clinical baseline day image ; Subjects must clinically stable order participate study . Baseline oxygen requirement . Blood oxygen saturation 92 % less measured pulse oximetry day image . FEV1 percent predict less 25 % . Pregnancy lactation . Claustrophobia , inner ear implant , aneurysm surgical clip , metal foreign body eye , pacemaker contraindication MR scanning . Subjects implanted device verify MRI compliant exclude . Chest circumference great xenon MR coil . History congenital cardiac disease , chronic renal failure , cirrhosis . Inability understand simple instruction hold still approximately 10 second . History respiratory infection within 2 week prior MR scan . History heart attack , stroke and/or poorly control hypertension . Known hypersensitivity albuterol component , levalbuterol .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Hyperpolarized Xenon</keyword>
	<keyword>HXe</keyword>
	<keyword>MagniXene</keyword>
</DOC>